Currently out of the existing stock ratings of Graham Doyle, 15 are a BUY (30%), 22 are a HOLD (44%), 13 are a SELL (26%).

Graham Doyle

Work Performance Price Targets & Ratings Chart

Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 36.51% that have a potential upside of 6.1% achieved within 72 days.

Graham Doyle’s has documented 80 price targets and ratings displayed on 7 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on PHG, Koninklijke Philips NV ADR at 03-Aug-2026.

Wall Street Analyst Graham Doyle

Analyst best performing recommendations are on GEHC (GE HEALTHCARE TECHNOLOGIES).
The best stock recommendation documented was for GEHC (GE HEALTHCARE TECHNOLOGIES) at 5/5/2025. The price target of $73 was fulfilled within 7 days with a profit of $3.79 (5.48%) receiving and performance score of 7.82.

Average potential price target upside

SNN Smith & Nephew SNATS PHG Koninklijke Philips NV ADR FMS Fresenius Medical Care FSNUY Fresenius SE KGaA ADR ALC Alcon AG GEHC GE HealthCare Technologies CL Colgate-Palmolive Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Aug-2024

1 months 29 days ago
(06-Aug-2026)

7/13 (53.85%)

$-7.2 (-32.01%)

627

Hold Since 28-Feb-2024

2 months ago
(05-Aug-2026)

12/17 (70.59%)

$-8.4 (-37.35%)

305

Hold Since 17-Mar-2025

$30

$-0.04 (-0.13%)

$35

4 months 24 days ago
(11-May-2026)

5/6 (83.33%)

$0.9 (3.09%)

16

Buy Since 09-Dec-2025

$39

$8.96 (29.83%)

9 months 26 days ago
(09-Dec-2025)

0/1 (0%)

$6 (18.18%)

Buy Since 29-Jan-2025

$37.5

$7.46 (24.83%)

11 months 21 days ago
(14-Oct-2025)

2/4 (50%)

$2.24 (6.35%)

762

Show more analysts

Please expand the browser size to see the chart

Which stock is Graham Doyle most bullish on?

Potential upside of $2.71 has been obtained for GEHC (GE HEALTHCARE TECHNOLOGIES)

Which stock is Graham Doyle most reserved on?

Potential downside of -$0 has been obtained for PHG (KONINKLIJKE PHILIPS NV ADR)

What Year was the first public recommendation made by Graham Doyle?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?